
Medical Fluorocarbon Materials Developer

Financial Services Institution
JunFuture (Jiangsu) Biomedicine Co., Ltd. (hereinafter "JunFuture") has recently closed a multi‑million‑yuan Pre‑A round of financing, with investors including HUAYIN FINANCIAL INVESTMENT and Taizhou Angel Investment Fund (Limited Partnership). The proceeds will be mainly used for R&D of the company's core pipeline, GMP production capacity buildout, and registration filings for its Phase I fluorocarbon API and pharmaceutical excipient project in Taizhou.

JunFuture: Jiangsu Tailing API Project
Founded in 2021 and headquartered in Nanjing's Jiangbei New Area, JunFuture has built R&D and production bases in Zibo, Taizhou, and other locations. With "countdown to the evolution of life" as its core mission, the company is led by talent including chief scientists of national major science and technology projects, authoritative experts of the Chinese Medical Association, and a globally highly cited researcher from MIT, and is dedicated to advancing new technologies and new materials in future medicine.

Four Major Innovative Drug Platforms in Fluorocarbon Medicine
At present, the company is focused on advancing the fully self-reliant industrialization of medical fluorocarbons. This covers, upstream, process development and scaled cGMP production capacity buildout for fluorocarbon APIs, and downstream, the development of innovative drug and medical device pipelines based on fluorocarbon medicine (injectable, ophthalmic, topical, and inhaled), benchmarked against leading US and European companies such as NuvOX, Novaliq, and Fluoron, so as to build more differentiated competitive advantages and a more complete capacity for industrial-chain self-reliance.
Medical fluorocarbons (surface-fluorinated small-molecule alkanes, often liquid or gaseous) are a class of biomedical materials of great strategic value. Thanks to their unique biological inertness and extremely high gas solubility, they have a long history of use in ophthalmic surgical filling and contrast imaging. Recently, as fluorocarbon materials have shown enormous market potential in eye drops, artificial blood, and life support (organ perfusion and preservation, military and space medicine), the global medical fluorocarbon market is experiencing rapid growth.

Main Applications of Medical Fluorocarbons